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T Seminal recent studies that have shed new light on the remarkable proper-
ties of clay interactions suggest unexplored opportunities for biomaterial 
design and regenerative medicine. Here, recent conceptual and technological 
developments in the science of clay interactions with biomolecules, polymers, 
and cells are examined, focusing on the implications for tissue engineering 
and regenerative strategies. Pioneering studies demonstrating the utility of 
clay for drug-delivery and scaffold design are reviewed and areas for future 
research and development highlighted.  1. Introduction 
 Recent reviews of the tissue engineering/regenerative medi-
cine (TERM) fi eld have increasingly emphasized the decisive 
contribution of the tissue engineering matrix in harnessing the 
regenerative potential of stem and progenitor cells. [ 1–6 ] Whereas 
previously, distinctions were drawn between “inductive” growth 
factors and “conductive” scaffolds, technological developments, 
predominantly in biomaterial design and testing, have made 
such demarcations increasingly hard to maintain. The dynamic 
infl uence of the matrix in controling the spatio-temporal distri-
bution of biochemical signals, [ 7 ] the metabolic signifi cance of 
matrix components, diffusive properties and degradation rate, 
and products, [ 3 , 6 ] the instructive role of transmitted mechanical 
forces, [ 8 ] and the still surprising impact that micro- and nano-
topographical features have on cell behavior, [ 2 , 9,10 ] all point to 
a signifi cance far beyond the conventional and indeed vital 
conductive role the scaffold fulfi lls as cell delivery vehicle, and 
three-dimensional support structure. 
 This expanding remit for the tissue engineering matrix 
is daunting, yet while considerable challenges still remain, 
the concurrent expansion of scaffold technology provides a 
wealth of approaches to addressing this complexity. Indeed, 
the expanding catalogue of scaffold materials and technolo-
gies, as well as constituting a response to pre-defi ned cellular 
and clinical design constraints, [ 11 ] has itself generated new and 
unforeseen insights into the diverse role of the cell matrix in 
tissue development, regeneration, and repair with signifi cant 
therapeutic implications. © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Adv. Mater. 2013, 25, 4069–4086 There are vistas of opportunity in the 
materials science fi eld that are only starting 
to be explored for regenerative applica-
tions. The focus of this review provides 
one such example. Recent studies investi-
gating, for the fi rst time, clay nanoparticles 
for cell-based regenerative strategies sug-
gest the striking potential of clay minerals 
to provide new opportunities for biomate-
rial design. The well-established utility of 
clay nanoparticles to interact with drugs 
and other biological molecules for con-
trolled delivery, and their ability to interact with polymers to enhance mechanical properties as seen in the 
development of polymer-clay nanocomposites are both of pro-
found relevance to TERM. However, to date, clay minerals are 
only beginning to be investigated in the development of bioma-
terials. A literature search of experimental studies investigating 
clay with stated reference to TERM as an application, uncovered 
less than 100 citations prior to 2013, and only 31 studies have 
assessed cellular responses to biomaterials incorporating clay. 
Furthermore, most have investigated clay minerals with a view 
to the mechanical-benefi ts conferred by polymer-clay interac-
tions, and thus the potential to harness clay biomolecule interac-
tions for TERM strategies remains largely unexplored ( Figure  1 ). 
 After briefl y surveying the use of clay minerals in medicine 
and the underlying chemistry from which their utility derives, 
this Progress Report will highlight the recent advances in both 
the characterization and functional application of clay interac-
tions that is driving a growing interest in this area of research. 
As well as reviewing the pioneering studies demonstrating 
enhanced stem and progenitor cell proliferation and differentia-
tion in response to clay mineral substrates and matrices, related 
advances derived from the application of clay in the fi elds of 
drug-delivery and polymer nanocomposites are reviewed. 
Thus, this Progress Report highlights the unique opportuni-
ties afforded by clay interactions with: i) biomolecules, allowing 
new options for matrix protein, growth factor, and gene delivery 
for tissue-regeneration; ii) polymers, for the generation of clay–
polymer composites with enhanced mechanical properties; iii) 
and cells, suggesting new opportunities for functionalization of 
gels and surfaces for enhanced regenerative responses. 
 2. Clay and Medicine: an Overview 
 The use of clays for medicinal purposes extends back into pre-
history. Archaeological evidence suggests application of clay to 
wounds and skin irritations by  Homo erectus and  H. neander-
thalensis , and, in the ancient world, frequent written attestation 4069wileyonlinelibrary.com
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developing approaches for bone and cartilage formation. is given to the ingestion of clay-containing earths to treat 
stomach and intestinal problems. [ 16,17 ] Their application as 
active ingredients continues to the present day where clays are 
applied orally as antacids, gastrointestinal protectors and anti-
diarrhoeics, and topically in various cosmetic creams, powders, 
and emulsions. [ 18 ] Furthermore, modern pharmaceutics employ 
clays as excipients acting variously as lubricants, diluents, fl avor 
correctors, emulsifi ers, rheological agents, and drug delivery 
modifi ers. [ 19 ] 
 Clay minerals are typically layered silicate structures (phyl-
losilicates) that crystallize into micro- and nanometer-sized 
particles. The small particle size combined with the perma-
nent structural charge of certain clays, notably those in the 
smectite class such as montmorillonite (MMT), saponite, 
and hectorite, results in signifi cant surface reactivity which 
has profound implications in marine and terrestrial eco-
systems, and provides the basis for a wide range of indus-
trial, environmental, and agricultural applications. [ 20,21 ] The 
long history of the use of clay minerals in the context of 
human health and disease is largely attributable to this rich 
electrochemistry. 
 In the case of smectites, the unit structure consists of lay-
ered sheets each constituted by two tetrahedral silica sheets 
sandwiching an octahedral sheet formed from a metal cation 
such as Al 3 +  or Mg 2 +  ( Figure  2 a). The smectite sheets are there-
fore isostructural with talc (ideally Mg 3 Si 4 O 10 (OH) 2 ) or pyroph-
yllite (ideally Al 2 Si 4 O 10 (OH) 2 ), but whereas the 2:1 sheets of 
talc are electrostatically neutral, the layers of the smectites 
possess a net negative charge (0.2–0.6 per half unit cell) due 
to random isomorphic cation substitutions in the octahedral 
and tetrahedral sheets compensated by hydrated interlayer 
cations. [ 20 ] Compared with certain other 2:1 clay minerals such 
as illite and vermiculite, the net negative charge of smectites 
remain relatively weak allowing the interlayer spacing between 
associated unit layers to expand from 9.6 Å when dehydrated 
(or in the absence of alternative polar molecules) to complete 
delamination of individual layers (Figure  2 b). [ 22 ] As well as the 
structurally generated negative surface charge, broken bonds 
at the crystal edges with unsatisfi ed valences yield localized 
positive charges (or negative charges at high pH) which play 
an important role in the colloidal properties of clay particle 
suspensions. The propensity for swelling and delamination of 
the charged smectite particles, gives rise to a rich selection of 
potential interactions between organic molecules and the clay 
particle surfaces, inter-layer pores and inter-particle spaces 
involving a range of mechanisms including cation exchange, 
hydrophobic interactions, hydrogen bonding, cation bridging, 
anion exchange and proton transfer depending on ambient 
pH, and the size and electrostatic properties of the interacting 
molecule ( Figure  3 ). [ 22 ] 
 Other relevant classes of clay mineral include kaolinite, 
palygorskite, and sepiolite. Kaolinite is a 1:1 tetrahedral octahe-
dral phyllosilicate, the units of which stack to a greater degree 
than other clays. The layers of kaolinite are held together 
by hydrogen bonding supplemented with dipole-dipole and 
van der Waals interactions. The result is that kaolinite tends 
not to undergo interlayer expansion in water, though swelling 
can be induced in contact with certain compounds such as 
those able to form hydrogen bonds with the inter-layer surface wileyonlinelibrary.com © 2013 WILEY-VCH Verlag G(e.g., hydrazine, amides, urea). [ 23 ] The large degree of stacking 
signifi cantly increases the electrochemical importance of the 
amphoteric edge surfaces, which exert a positive charge in 
acidic conditions and a negative charge above approximately 
pH 7. [ 22,23 ] Palygorskite and sepiolite are hydrous magnesium 
silicates. Their 2:1 layered crystals form elongated ribbons 
rather than continuous sheets (as with smectites) formed by 
stepped linkages that result in a gross fi brous morphology 
incorporating channels along the fi ber lengths. Substitution of 
aluminum by magnesium in the octahedral layers yield a mod-
erately high permanent surface charge which, given the chan-
neled fi brous structure, imparts a high sorptive capacity. In 
suspension palygorskite exhibits high viscosity that is derived 
from physical entanglement rather than electrostatic interac-
tion (as with smectites) and which is, thus, stable in an ionic 
medium. [ 23,24 ] 
 The direct therapeutic relevance of the properties outlined 
can be briefl y illustrated by returning to the list of pharmaceu-
tical applications involving clays as active ingredients. Clays 
(principally palygorskite and smectites) are widely applied 
as antacids, with the postulated mechanism being the pro-
pensity to absorb protons to the mineral surface resulting in mbH & Co. KGaA, Weinheim Adv. Mater. 2013, 25, 4069–4086
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 Figure  1 .  Clay interactions for TERM. Clay-biomolecule interactions, clay-polymer interactions, clay-cell interactions, and their combination are increas-
ingly the subject of study in biomaterial design for application in TERM. a) Biomolecule interactions with clays allow the localization and delivery 
of proteins and growth factors. Adapted with permission. [ 12 ] Copyright 2011, Wiley-VCH. b) Polymer interactions with clays allow the generation of 
composites with enhances mechanical strength and toughness. Adapted with permission. [ 13 , 14 ] Copyright 2002, 2006, American Chemical Society. c) 
Cellular interactions with clay minerals allow the functionalization of surfaces and gels for enhanced cell responses. Adapted with permission. [ 15 ] Copy-
right 2012, Wiley-VCH. The Venn diagram displays the number of studies investigating these interactions that cite TERM as a potential application.. mineral decomposition into silica gel and structural or inter-
layer cations which are released as excretable products. [ 18 ] As 
gastrointestinal protectors, the interaction of clay particles with 
mucosal glycoproteins mediates glycoprotein polymerization, 
thus stabilizing the protective mucosal barrier. [ 25 ] Hence, smec-
tites have been applied to successfully treat the symptoms of 
gastritis caused by non-steroidal anti-infl ammatory drugs. [ 25 ] 
Smectite use in the treatment of symptomatic diarrhea derives 
from their ability to swell to absorb excess water and aid the 
compaction of feces. The high sorptive capacity of the silica 
gel that results in the acidic medium is thought to further 
aid anti-diarrheic action. [ 16–18 ] As topical agents clay minerals 
(principally kaolinite, talc, and smectites) confer benefi t by 
adhering to the skin, forming a protective fi lm. Their sorptive 
capacity for grease and toxins is also frequently suggested in 
reviews of the subject. [ 16–18 ] 
 The sorptive properties of clay have also been widely investi-
gated for their indirect therapeutic utility in the context of drug 
delivery and, recently, tissue regeneration. The recent develop-
ment of polymer–clay nanocomposites have generated renewed 
interest in the properties of clay minerals and their utility to 
generate new functional materials, including biomaterials, with 
unique mechanical properties. Thus, alongside, classic clay–
protein interactions, clay–polymer and, increasingly, clay–cell 
interactions are being investigated for their potential in various 
therapeutic strategies. It is these interactions and their combi-
nation for application in the design of biomaterials for tissue 
engineering and regenerative medicine that provides the focus 
of the rest of this report. © 2013 WILEY-VCH Verlag GmAdv. Mater. 2013, 25, 4069–4086 3. Clay-Biomolecule Interactions 
 3.1. Proteins and Peptides 
 While the interaction of clay minerals with biological molecules 
has been recognized for over a century [ 26 ] it was in the 1960s that 
its signifi cance for medical applications began to be appreciated. 
Early studies observed reduced systemic availability of drugs 
co-administered with clay-based antacids and anti-diarrheal 
treatments, an observation which prompted investigation into 
the utility of clays as drug-delivery modifi ers able to delay the 
release or localize the application of therapeutic molecules. [ 27 ] 
 The complex charge structure of proteins and potential for 
conformational entropy, combined with the rich electrochem-
istry of clay minerals facilitates a wide range of possible interac-
tions and affi nities that defy easy prediction. [ 28,29 ] While electro-
static interactions are dominant, van der Waals and hydrophobic 
interactions are also signifi cant and infl uenced by the internal 
cohesion of the protein secondary and tertiary structure. The 
several possible points of contact between clay and protein 
surfaces mean that high affi nity (h-type) adsorption isotherms 
often pertain along with minimal desorption upon dilution. [ 30 ] 
 Recent studies have employed phage display techniques that 
allow the screening of extremely large libraries ( > 1  × 10 9 ) of 
7–12 amino-acid length peptides, to identify sequences that bind 
to nanosized silica surfaces. [ 28,29 , 31,32 ] There was considerable 
diversity observed in the sequences of the most tightly bound 
peptides both between studies and as a result of experimentally 
controlled changes to the silica conformations, suggesting the 4071wileyonlinelibrary.combH & Co. KGaA, Weinheim
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 Figure  2 .  a) Smectite crystals are constituted by two tetrahedral silica sheets sandwiching an octahedral sheet formed from a metal cation such as 
Al 3 +  or Mg 2 + . Charge defi ciencies in the octahedral and/or tetrahedral layers yield a negative surface charge balanced by exchangeable cations. b) The 
different crystal structures of clays yield various colloidal properties and stacking arrangements. Compared with other clays, the relatively weak surface 
charge of smectites allows the complete delamination of individual layers. 
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bhigh sensitivity of the silica-peptide interaction and, importantly, 
the existence of a range of binding mechanisms. [ 29 ] For example, 
in a study of peptide binding to MMT, while the most strongly 
binding peptide contained positively charged Lysine side chains 
that at pH 7 underwent an ion exchange reaction with the 
clay surface, another strong binder lacked any cationic groups 
and was bound via coordination of alkali ions and hydrogen 
bonds. [ 28 ] Computer-simulations of the cation exchanged pep-
tide suggested peptide conformational changes between the free 
and the adsorbed state, but that these changes were sequence 
specifi c and thus, not amenable to generalization. [ 31 ] The iden-
tifi cation of many peptide sequences showing affi nity for silica 
surfaces stands in sharp contrast with equivalent studies on 
other surfaces such as gold, silver, and gallium arsenide, for 
which there was considerable convergence between high affi nity 
sequences. [ 29 ] This approach is now being explored as a means 
to functionalize clay surfaces via covalent attachment of high 
affi nity peptides to target molecules. [ 28 , 32 ] 
 3.2. Nucleic Acids 
 As well as proteins and peptides, the adsorption of nucleic 
acids onto clay mineral systems has also been extensively 2 wileyonlinelibrary.com © 2013 WILEY-VCH Verlag Gmstudied in the context of soil ecology due to the capacity of 
smectite-adsorbed DNA in soil, to transform competent bacte-
rial cells. [ 33–35 ] In addition, smectites, particularly MMT, have 
long been proposed as catalytic surfaces for the putative poly-
merization of RNA oligomers in the "RNA World" hypothesis 
for the origin of biologic life. [ 36 ] Model systems demonstrating 
this potential have since been developed. [ 37,38 ] 
 Studies within these fi elds have shown that DNA binding 
to MMT is not via intercalation as X-ray diffraction analysis 
indicates basal inter-gallery spacing remains the same fol-
lowing DNA absorption, but rather binding principally occurs 
on the edges of the clay particles. [ 39 ] The extent of adsorption is 
greatest for chromosomal DNA compared with plasmid DNA 
and 25S RNA, [ 40 ] and DNA adsorbed on MMT retains its orig-
inal conformation. [ 34 ] Importantly, several studies have dem-
onstrated protection of clay-bound DNA from degradation by 
nucleases, [ 33,34 , 40,41 ] which is thought to occur through their co-
adsorption onto the clay preventing DNA degradative interac-
tion. [ 34 ] The bioavailability of adsorbed nucleic acids have been 
assessed in the contexts of these two fi elds in terms of their 
transformative ability in competent bacteria [ 41 ] and availability 
for reverse transcriptase replication. [ 36 ] In both cases, effi ciency 
was reduced but not eliminated with clay-bound compared to 
free nucleic acids. bH & Co. KGaA, Weinheim Adv. Mater. 2013, 25, 4069–4086
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 Figure  3 .  a) Smectites (here, the synthetic hectorite Laponite, [(Si 8 Mg 5.5 Li 0.3 ) O 20 (OH) 4 ]  − 0.7 ) possess a permanent negative surface charge arising from 
isomorphic substitutions in the crystal structure and a pH dependent edge charge from unsatisfi ed valences in the disrupted crystal lattice. b) Potential 
interactions between organic molecules and the clay particle surfaces, inter-layer pores and inter-particle spaces involving a range of mechanisms   3.3. Therapeutic Delivery of Biomolecules 
 The rich array of possible interactions between clay and bio-
logical molecules suggests exciting possibilities for biomolecule 
delivery. In the context of oral drug delivery, typical pharmaco-
logical formulations involve dispersing clay particles in drug 
solutions and, following equilibration, recovery of the drug-clay 
complex as a solid phase for delivery in tablet form. Thus, the 
intercalation of vitamin B 6, [ 42 ] timolol maleate, [ 42 ] itraconazole, [ 43 ] 
donepezil, [ 44 ] and venlafaxine [ 45 ] into smectite particles has 
recently been investigated for controlled oral delivery. [ 21 , 27 , 46,47 ] 
 The potential to employ clay nanoparticles for non-viral gene 
delivery is also being explored. The protective effect of clay par-
ticles has been convincingly demonstrated by the ability of clays 
to mediate the transfection of gastro-intestinal cells following 
oral delivery of DNA clay-complexes. In contrast to the delivery 
of naked DNA and DNA complexed with the widely used poly-
ethyleneimine vector, detection of low levels of green fl uores-
cent protein (GFP) transfection via polymerase chain reaction © 2013 WILEY-VCH Verlag GmAdv. Mater. 2013, 25, 4069–4086following delivery with MMT indicated protection against DNA 
degradation within both the acidic environment of the stomach 
and the nuclease-rich intestinal environment. [ 48 ] The layered 
silicate rectorite was employed to enhance the utility of chi-
tosan as a gene delivery vector. Incorporation of rectorite signif-
icantly improved the complexation of DNA compared with chi-
tosan alone and enhanced the transfection effi ciency to achieve 
90% transfection after 5 days in vitro. Robust GFP expression 
in the gastrointestinal tract following oral delivery again indi-
cated the protective effect of the clay on the plasmid. [ 49 ] Another 
approach employed alkylammonium cations to expand the 
interlayer spacing of MMT for intercalation of DNA to achieve 
transfection of dermal fi broblasts, albeit at a low effi ciency. [ 50 ] 
 3.4. Clay-Modifi ed Biomolecule Delivery from Matrices 
and Hydrogels 
 Important to the function of the TERM matrix or scaffold is the 
ability to control, in space and time, the retention and release 4073wileyonlinelibrary.combH & Co. KGaA, Weinheim
4074
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 Figure  4 .  The incorporation of clay nanoparticles into polymeric matrices slows biomolecule release through a range of mechanisms including a) 
reduced swelling of the polymer, b) slowed degradation of the polymer, c) impartation of barrier properties, and d) direct interactions. of bioactive molecules that stimulate and direct the growth 
and differentiation of tissue-progenitor populations. The char-
acteristic open polymer networks and high water content 
( > 90%) of hydrogels in particular, while facilitating the diffu-
sion of nutrients and contributing to the biocompatibility of the 
material, [ 51,52 ] makes the sustained bioavailability of encapsu-
lated molecules at the site of delivery a major challenge to be 
addressed prior to application. Typically, hydrogel encapsulation 
results in a burst-release response upon delivery, necessitating 
modifi cations to the polymeric network to retard the release 
of the biomolecule. [ 5 , 7 , 53 ] With the generation of polymer–clay 
nanocomposite material science, the incorporation of clay 
nanoparticles into polymeric tissue-engineering matrices and 
hydrogels suggests exciting potential as one such modifi cation 
for biomolecule localization and sustained release. 
 Interestingly, given the unique potential of clay particles 
for adsorption of biomolecules, their role in retarding drug 
release in the context of polymer–clay nanocomposites is rela-
tively infrequently attributed to direct interaction between the 
biomolecule and the clay. [ 46 , 54 ] This is possibly due to the fact wileyonlinelibrary.com © 2013 WILEY-VCH Verlag Gthat, to date, where nanocomposite materials have been applied 
to sustained delivery, clay–polymer interactions for altered 
mechano-physical properties (reviewed below) have dominated 
in the design process over clay–biomolecule interactions. [ 54 ] 
For example, where retardation of protein (albumin) release 
was observed as a function of clay particle content in a dried 
poly(ethylene oxide) (PEO) hydrogel fi lm, the slowing of release 
was attributable to a reduction in swelling of the polymer net-
work due to increased clay cross-linkers rather than through 
direct association of the protein with the polymer-bound 
clay particles themselves. [ 55 ] Clay-mediated swelling effects 
impacting drug release have been observed in several other 
studies ( Figure  4 a). [ 46 , 56–60 ] 
 The effect on matrix dissolution or degradation is another 
important indirect mechanism by which drug release is modi-
fi ed by clay incorporation (Figure  4 b). Clay addition to a ther-
mosensitive triblock copolymer system was observed to slow 
the release of a model protein via reduced hydrogel dissolu-
tion. [ 61 ] Paracetemol diffusion from poly(ethylene glycol) (PEG) 
was likewise retarded by encasement with the modifi ed MMT, mbH & Co. KGaA, Weinheim Adv. Mater. 2013, 25, 4069–4086
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polymer. [ 62 ] Conversely, addition of MMT nanoparticles to poly-
urethane increased the rate of the release of dexamethasone 
acetate, by increased water adsorption and thus, hydrolysis of 
the polymer. [ 63 ] 
 Slowed biomolecule release with incorporation of small frac-
tions of exfoliated clay particles is most frequently accounted 
for by the impartation of barrier properties to polymer sub-
strates that slow release via more tortuous diffusion paths 
(Figure  4 c). [ 46 , 54 , 64–66 ] For example, addition of Cloisite clay to 
poly(ethylene-co-vinyl acetate) slowed the rate of dexametha-
sone release from the polymer matrix, critically as a function of 
the aspect ratio (as well as the volume fraction) of the dispersed 
organosilicate particles. The authors suggest barrier properties 
could be harnessed by combining carefully selected silicates of 
different sizes to tune release profi les. [ 67 ] 
 However, in several studies, direct clay–biomolecule interac-
tions have indeed been shown to impact biomolecule release 
(Figure  4 d). Lee et al . [ 59,60 , 68 ] investigated the effect of clay 
minerals on the swelling and drug release properties of two 
hydrogels. Incorporation of bentonite into a mucoadhesive 
polymeric hydrogel composed of acrylic acid (AA) and poly-
(ethylene glycol) methyl ether acrylate, [ 60 ] and incorporation of 
MMT into a poly(N-isopropylacrylamide) (PNIPA) hydrogel [ 59 ] 
in both cases decreased the swelling and increased the strength 
of the hydrogel. Drug release was again altered indirectly as a 
function of reduced swelling, but also directly via electrostatic 
attraction of positively charged molecules (decreasing the rate 
of release) and electrostatic repulsion of the negatively charged 
molecules (increasing the rate of release). [ 59,60 ] The introduc-
tion of an intercalation agent with MMT further reduced the 
swelling ratio but attenuated the previously described effect of 
the clay mineral on the drug release profi le of the gel. [ 60 ] 
 The development of clay–chitosan polymer nanocomposites 
is particularly important in relation to biomolecule delivery 
in the context of tissue regeneration. Chitosan is a natural 
polymer derived from partially (75%) deacetylated chitin with 
wide application as a polyelectrolye and chelating agent as well 
as use as a matrix material for regenerative applications. Inter-
calation of chitosan into smectites via amine induced cation 
exchange [ 69 ] has been extensively investigated for a range of 
applications including drug delivery and, recently, tissue engi-
neering. [ 57 , 69–78 ] The intercalation of sodium modifi ed MMT 
with chitosan was found to attenuate by competition the strong 
cationic exchange capacity of the clay increasing the release of 
an adsorbed cationic drug over time. [ 75 ] Importantly, the clay 
mineral in this case was pre-loaded with the drug prior to for-
mation of the chitosan–clay nanocomposite and thus the clay–
drug interaction was dominant in slowing release (represented 
schematically in Figure  4 d). Subsequent incorporation of chi-
tosan undermined this interaction in proportion to the ratio 
of chitosan to clay, providing a means to tune drug release. [ 75 ] 
Interestingly, continued increase in the chitosan content rela-
tive to the cation exchange capacity of the clay has been found 
to generate the formation of bilayers of chitosan via hydrogen 
bonding between the amino and hydroxyl groups of the chi-
tosan and clay substrate. As a result, exchange sites available 
for the adsorption of anionic drugs arise adding to the versa-
tility of this system for biomolecule delivery. [ 69 ] © 2013 WILEY-VCH Verlag GAdv. Mater. 2013, 25, 4069–4086 The utility of chitosan modifi ed sodium MMT for sustained 
drug release has recently been applied in the development of 
a macroporous polycaprolactone (PCL) based scaffold for bone 
tissue engineering. [ 78 ] Specifi cally, a PCL scaffold embedded 
with  β -tri-calcium-phosphate and chitosan to enhance osteocon-
ductivity, was loaded with chitosan-modifi ed clay nanoparticles 
in order to sustain the release of the cationic broad-spectrum 
anti-tumor drug, doxorubicin. The rationale for biomolecule 
delivery in this case was the treatment of residual osteosarcoma 
following excision and prior to bone regeneration. Whereas in 
the absence of clay incorporation 95% of the drug was released 
within 4 days, release of the drug incorporated in association 
with chitosan modifi ed clay particles was sustained for over 
two months. Critically, in the absence of chitosan modifi cation, 
clay particle addition retarded release to less than 10% after 1 
month. [ 78 ] 
 3.5. Clay-Mediated Biomolecule Localization 
 While classic drug-delivery strategies focus on the release 
properties of the delivery vehicle, regenerative strategies often 
require the presence and activity of the biomolecule to remain 
localized within or upon the tissue engineering matrix. This is 
especially the case for matrix molecules that facilitate cell adhe-
sion and migration. The facility of clay in this regard has been 
underlined in the development of nanocomposite fi lms through 
an approach known as layer-by-layer assembly. [ 79–82 ] In one par-
ticular study, addition of a fi nal (top) layer of clay particles upon 
sequentially layered poly(diallyldimethylammonium chloride) 
(PDDA)/MMT clay surface fi lms, was found to be necessary 
for the sustained presence of the matrix molecules fi bronectin 
and type IV collagen which, in turn, were found to enhance cell 
adhesion and growth upon the layered fi lms. [ 80 ] The observed 
impact of clay nanoparticle incorporation on improving cell 
adhesion in other nanocomposite approaches (reviewed below) 
has also been attributed, at least partly, to the role played by the 
clay particles in adsorbing adhesive proteins such as fi bronectin 
and vitronectin from serum. [ 83–87 ] 
 Our group has explored the potential to localize active 
molecules through electrolyte-induced formation of gel cap-
sules from pristine clay particles ( Figure  5 ) with the aim of 
developing chemically defi ned niches for stem-cell mediated 
regeneration. Flocculation of clay particles in electrolyte solu-
tions signifi cantly enhances the sorptive capacity of clay and 
facilitates the entrapment of active molecules. [ 88 ] Pre-dispersed 
nano-suspensions of the synthetic hectorite, Laponite dis-
played high and broad-spectrum affi nity for proteins in saline 
solution (including cell culture media) following drop-wise 
addition and resultant gelation. Negligible release of either 
albumin (66.4 kDa, PI, 4.7) or lysozyme (14.4 kDa, PI, 11) 
from the clay gel capsules was observed and, furthermore, 
clay–gel capsule formation induced active uptake of the two 
proteins from the media via sorption to the gel capsule sur-
face ( Figure  6 a). The utility of this approach to generate niches 
for tissue regeneration was demonstrated both with the matrix 
molecules fi bronectin and type I collagen, and the angio-
genic vascular endothelial growth factor (VEGF). Addition of 
fi bronectin and type I collagen into clay gel fi lms stabilized 4075wileyonlinelibrary.commbH & Co. KGaA, Weinheim
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 Figure  5 .  Clay gel encapsulation via controlled fl occulation in response to electrolyte. a) Drop-
wise addition of hydrated Laponite suspensions to various concentrations NaCl  −  yields gel 
capsules as electrolyte concentration increases. b) Encapsulation of MG63 cells in Laponite via 
drop-wise addition to cell culture media. c) Atomized clay suspensions added to cell culture 
media allows single cell encapsulation. d) Recovery of microcapsules via centrifugation allows 
sub-encapsulation in clay gels to generate spatial complexity in an injectable system. Adapted 
with permission. [ 12 ] Copyright 2011, Wiley-VCH. the tubule formation of cultured endothelial cells (Figure  6 b), 
co-encapsulation of fi bronectin into clay gel capsules enhanced 
the chondrogenic differentiation of mesenchymal stem cells, 
and active uptake by clay gels of exogenously applied VEGF 
enhanced angiogenesis when the gels were implanted into a 
murine femoral defect (Figure  6 c). [ 12 ] 
 3.6. Clay-Protein Interactions and Clay Induced Hemostasis 
 Finally, it is worth noting in the context of clay-protein 
interactions, the well-established facility of clay minerals 
to induce a hemostatic response. Kaolinite has been used 
since the 1950s as a clotting agent in clinical assays of blood 
hemostasis and more recently clay minerals have been 
applied to wound dressing materials. QuickClot, a commer-
cially available zeolite composite material has been shown to 
control bleeding in several animal models of lethal hemor-
rhage, [ 89,90 ] and other dressings incorporating kaolinite [ 91,92 ] wileyonlinelibrary.com © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weior smectites [ 93 ] have also demonstrated 
strong clotting responses. Baker et al. [ 94 ] 
have investigated the mechanism of action 
of clay mineral induced hemostasis and 
the differential blood clotting response to 
a range of layered minerals which present 
varying structural and surface properties. 
The study observed a strong correlation 
between hemostatic efficiency and the 
strength of the zeta-potential of clay parti-
cles in simulated body fluid. The authors of 
the study suggested the correlation between 
clay surface charge and clotting efficiency 
to be due to the enhanced absorption and 
activation of blood coagulation factor XII 
on the more negatively charged clay sur-
faces in the presence of plasma proteins. [ 94 ] 
 These interesting results further underline 
the potential utility of clay-biomolecule inter-
actions in tissue regeneration. The induction 
of a clotting response through potential locali-
zation of factors and cytokines is of direct rel-
evance to regeneration at sites of trauma. The 
potential to sustain the presence and activity 
of infl ammatory cytokines which stimulate 
the migration of progenitors would be of 
particular relevance in tissues with existing 
regenerative capacities such as bone where 
the formation of a clot and then callous are 
vital steps in the regenerative sequence. Of 
course, the same facility to retain infl amma-
tory cytokines at an injury site is not purely 
benefi cial, and so the ability to control and 
tune these interactions will likely be an 
important prerequisite for the safe and effi -
cient utility of clay particles in regenerative 
interventions.  4. Clay-Polymer Interactions 
 4.1. Clay-Polymer Nanocomposites 
 The challenging design specifi cations for functional biomate-
rials has driven the investigation and application of polymer 
nanocomposites that not only combine the respective benefi ts 
(and overcome the respective weaknesses) of organic and inor-
ganic based materials but derive new emergent properties of 
critical relevance for TERM. [ 64 ] Bone tissue sets the evolutionary 
precedent for this approach. [ 95,96 ] The presence of a hydroxyapa-
tite phase at the nanoscale of the hierarchically ordered (from 
molecular to macro-scale) collagen phase accounts for the 
high compressive strength of bone tissue, imparts to bone its 
vital role in mineral homeostasis and is of key signifi cance 
for the differentiation and function of skeletal and hemat-
opoietic cell populations. [ 97,98 ] These features that characterize 
bone as a nanocomposite (a polymeric structure incorpo-
rating a nanoscale inorganic phase that enhances mechanical nheim Adv. Mater. 2013, 25, 4069–4086
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 Figure  6 .  Biomolecule uptake and function in Laponite gels. a) Negligible release of model proteins was observed from Laponite gel capsules compared 
with alginate controls. Upon addition to saline solution containing protein, protein was taken up from the media and concentrated upon the surface of 
the gel capsule. Function of adsorbed protein was observed through premixing of the matrix molecules fi bronectin and type I collagen into clay gel fi lms 
to sustain b) network organization of endothelial cells in vitro (scale bars 100  μ m) and c) through pre-incubation of Laponite gels in VEGF solutions 
to induce an in vivo angiogenic response in a murine femoral defect. Adapted with permission. [ 12 ] Copyright 2011, Wiley-VCH. 
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aand chemical/biological properties) apply also to the develop-
ment and goals of nanocomposites and their application in 
the context of TERM. [ 99 ] Although initially developed for their 
potential to dramatically improve the mechanical properties 
of the polymer substrate, the biological signifi cance of a clay 
nano-component for cell behavior is increasingly apparent as 
polymer–clay nanocomposites are investigated for biomaterial 
applications. In this section, the application of clay–polymer 
interactions for enhanced mechanical properties for regenera-
tive strategies will be discussed before reviewing recent studies 
exploring the nature and signifi cance of clay-incorporation for 
cellular interactions. 
 The potential of clay nanoparticle incorporation for the gen-
eration of polymeric materials with improved mechanical prop-
erties is attested to by the impressive volume of literature that 
has been generated on the subject in the last 10 years and their 
increasing application in almost all areas of modern industrial 
development and production. [ 100 ] In the context of biomedical 
applications, inorganic clay mineral (along with silicon and 
calcium phosphate) nano-phases are increasingly being incor-
porated into polymers with established biocompatibility for 
the sake of enhancing the mechanical and degradation proper-
ties of the polymeric base. [ 64 , 101 ] Typical improvements to the 
mechanical properties include enhanced tensile or compressive © 2013 WILEY-VCH Verlag GAdv. Mater. 2013, 25, 4069–4086strength, enhanced modulus, elongation, toughness, and/or 
impartation of viscoelastic, or other responsive properties such 
as self-healing ( Table  1 ). 
 4.2. Clay–Polymer Nanocomposite Porous Scaffolds 
 Clay nanoparticles have been applied to porous polymer scaf-
folds to enhance compressive strength and stiffness (mod-
ulus). [ 133–141 ] The combination of high porosity and compressive 
strength remains an on-going challenge in scaffold design for 
tissue engineering, particularly in bone repair, and polymer–
clay nanocomposites have demonstrated considerable potential 
in this regard. Such enhancements derive not only from the 
combined mechanics of each component, as is predominantly 
the case with ceramic or nanotube-based composites, but criti-
cally from interfacial interactions between the polymer and clay 
nanoparticle. [ 142,143 ] For this reason, signifi cant improvements 
to the modulus and strength of a material can be achieved with 
the addition of clay concentrations of under 5 wt%. 
 Given the importance of interfacial interactions, approaches 
that maximize their contribution to the composite structure 
by increasing the delamination and dispersion of individual 
clay particles are important in effecting improvements to 4077wileyonlinelibrary.commbH & Co. KGaA, Weinheim
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 Table  1.  Polymer–clay nanocomposites investigated with stated relevance to biomedical applications together with observed mechanical 
enhancements. 
Bulk class Polymer a) Clay b) Mechanical enhancement with clay c) Refs.
Tensile 
strength
 [MPa]
Tensile 
modulus 
[MPa]
Comp. 
strength 
[MPa]
Comp. 
modulus 
[MPa]
Elongation Toughness Dynamic 
properties d) 
Dried fi lm/
gel
Chitin–PU Bent- 36  [ 102 ] 
Chitosan–gLA MMT 260  [ 74 ] 
Gelatin MMT 89 2000  [ 103 ] 
PAA Bent- 0.4  +  [ 104 ] 
PDMAA Lap- 15  +  +  [ 105 ] 
PEO Lap- 60  + MR  [ 15 , 106 ] 
PGS Hallo- 1.6 1.5  +  [ 107 ] 
PI MMT 80 9000  [ 108 ] 
PLG MMT 35 2140  +  +  [ 109 ] 
PMEA Lap- 6.2 192  +  +  [ 105 , 110 ] 
PU MMT 62 43  +  + MR  [ 111 , 116 ] 
PVA Hallo- 60  +  +  [ 117 ] 
PVA MMT 320 5800  [ 118 ] 
Fibrous BC Lap- 227 21 000  [ 119 ] 
BC MMT 210 6100  [ 120 ] 
PCL Hall- 3.5 4.5  [ 87 ] 
PEO Lap- 45  + MR  [ 106 , 121 ] 
PLGA Hallo- 10 179  +  [ 122 ] 
Hydro-gel PAAM Hallo- 0.049 0.009 0.048  +  +  [ 123 ] 
PAAM Lap- 0.319 0.019  +  +  [ 124 ] 
PDMAA Lap- 0.255 0.015  +  + SH, SR  [ 105 , 125–126 ] 
PEG Lap- 0.56 3.73 0.038  +  +  [ 85 , 127–128 ] 
PEO Lap- 0.012 0.003 VE  [ 15 , 55 ] 
Pluronic Lap- 0.077  +  +  [ 129 ] 
PNIPA Lap- 1.6 43 5  + MR  [ 13–14 ] ,
 [ 130–131 ] 
PVA MMT 3.8  [ 132 ] 
Porous 
scaffold
Chitosan–
PGA
MMT 6.0  [ 133 ] 
Gelatin Sep- 0.3 6.0  [ 134 ] 
PCL MMT 11 420 3.6 43.1  [ 135–136 ] 
PLA MMT 7.2 68.4  [ 137–138 ] 
PLLA MMT 170  [ 139–140 ] 
PVA Sep- 0.4 15  [ 141 ] 
 a) BC, bacterial cellulose; gLA, g-lactic acid; PAA, polyester polyol acrylate; PAAM, polyacrylamide; PCL, poly(e-caprolactone); PDMAA, poly(N,N-dimethylacrylamide); 
PEG, poly(ethylene glycol); PEO, poly(ethylene oxide); PI, polyimide; PGA, polygalacturonic acid; PGS, poly(glycerol sebacate); Pluronic, Pluronic F127 diacrylate; PLA, 
poly(lactic acid); PLG, poly (lactide-co-glycolide); PLGA, poly(lactic-co-glycolic acid); PLLA, poly(l-lactic acid); PMEA, poly(2-methoxyethylacrylate); PNIPA, poly(N-isopro-
pylacrylamide); PU, polyurethane; PVA, poly(vinyl alcohol); BC, bacterial cellulose;  b) Bent, bentonite; Hallo, halloysite; Lap, Laponite; MMT, montmorillonite; Sep, sepiolite; 
 c) Maximum reported mechanical strength for each composite in MPa;  d) Dynamic mechanical properties include self-healing (SH), stimuli-responsive (SR) visco-elastic 
(VE) and mechano-responsive (MR) properties. mechanical properties. Organic modifi cation of MMT through 
the use of organic ions, such as quaternary ammonium com-
pounds, is commonly applied to increase the miscibility of the 
clay layers. In this way, the different degrees of miscibility in wileyonlinelibrary.com © 2013 WILEY-VCH Verlag Gpoly(l-lactic acid) (PLLA) that characterized modifi ed MMT-
based Cloisite clays, 15A, 25A, and 30B, were found to be sig-
nifi cant in enhancing the modulus of the polymeric fi lm pre-
pared using an exfoliation-adsorption method ( Figure  7 ). [ 140 ] mbH & Co. KGaA, Weinheim Adv. Mater. 2013, 25, 4069–4086
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 Figure  7 .  Increasing the delamination and dispersion of individual clay particles is important in effecting improvements to mechanical properties. 
a) Transmission electron microscopy images display various degrees of miscibility of modifi ed MMTs in PLLA b) along with the corresponding improve-
ment in mechanical properties. Adapted with permission. [ 140 ] Copyright 2003, American Chemical Society. Using the same approach, low concentrations (5.79%) of 
organically modifi ed MMT increased the tensile modulus of 
PLLA by 40% to allow the development of scaffolds of 90% 
porosity with a stiffness approaching that of intact trabecular 
bone. [ 139 ] Additional approaches to enhancing the dispersion 
of clay particles further improve mechanics. Ozkoc et al. [ 138 ] 
investigated the incorporation of Cloisite (30B) in porous 
poly(lactic acid) (PLA) scaffolds for bone tissue engineering 
and demonstrated the signifi cance of shear rate for achieving 
higher degrees of exfoliation of the clay and a resultant 
increase in compressive modulus. Their approach achieved 
scaffolds of 80% porosity with a compressive strength of 2 
MPa, a result signifi cantly higher than that typically reported 
for PLA matrices reinforced with calcium phosphates, sili-
cates or phosphate glasses [ 144 ] though still short of the 4–12 
MPa of trabecular bone. [ 138 ] The mechanical properties of 
PLA were further enhanced by Baker et al. [ 137 ] who employed 
supercritical carbon dioxide (scCO2) processing to simultane-
ously aid the dispersion of the clay nanoparticles and impart 
a porous structure to a Cloisite (93A)–PLA nanocomposite. 
Using this approach, nanocomposites containing 2.5% clay 
mineral achieved an average compressive strength of 7.15  ± 
2.02 MPa and an average compressive modulus of 68.42  ± 
32.41 MPa. [ 137 ] These approaches thus uniquely allow for the 
generation of hard porous scaffolds with strength and stiff-
ness approximating that of trabecular bone offer considerable 
promise for bone tissue engineering applications. 
 4.3. Clay-Polymer Nanocomposite Hydrogels 
 Perhaps the most dramatic enhancements to mechanical prop-
erties have been seen in the application of clay nanoparticles © 2013 WILEY-VCH Verlag GmAdv. Mater. 2013, 25, 4069–4086to hydrogels. Haraguchi and colleagues, in particular, have 
explored the interaction of Laponite in polymer gels of  > 90 wt% 
water to demonstrate the potential of this approach to generate 
new material properties. [ 13,14 , 84 , 105 , 110 , 125–127 , 130 , 145–147 ] Nano-
composite hydrogels based, in the fi rst instance, on PNIPA 
were found to display strength, modulus, and toughness sev-
eral orders of magnitude greater than the polymer in the 
absence of clay. [ 13 , 130 ] Such enhancements are attributable to 
the homogenous distribution of clay nanoparticles which act 
as non-covalent cross-linkages able to dissipate stress during 
deformation. [ 64 ] 
 Furthermore, the large size of the clay surfaces across which 
the polymer can form (and reform) multiple cross-linkages, 
generates physical hydrogels that combine unusually high 
mechanical strength with the capacity to self-heal allowing the 
potential for moldable and, in some cases, injectable biomate-
rials amenable for minimally invasive delivery. [ 15 , 64 , 105 , 126 , 148 ] 
 Several polymer–clay hydrogel systems have also 
been reported to display extremely large elastic deforma-
tions. [ 13,14 , 85 , 105 , 123–132 ] In contrast to the often brittle organic 
polymers alone, nanocomposite gels, especially containing 
low ( < 2%) concentrations of clay nanoparticles, characteris-
tically display the capacity for elongation in excess of 1000% 
with near complete recovery. The large degree of spacing 
between the clay cross-linkers allowing long and fl exible pol-
ymer chains, account for the considerable degree of deforma-
tion observed ( Figure  8 ). [ 13 , 145 , 147 ] Due to the extent of spacing, 
PNIPA nanocomposites incorporating higher clay contents (up 
to 12 wt%) could be generated, displaying a marked increase 
in both tensile modulus and strength while maintaining the 
capacity for elongations of up to 1000%. [ 14 ] These gels also 
displayed mechano-responsive properties whereby, following 
elongations beyond a critical point and subsequent recovery, 4079wileyonlinelibrary.combH & Co. KGaA, Weinheim
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 Figure  8 .  Nanocomposite hydrogels for enhanced mechanical properties. In contrast to a) organically cross-linked (OR) PNIPA polymer gels b,c) gels 
cross-linked with clay nanoparticles (NC) display marked improvements in strength, elongation and toughness (numbers represent relative crosslink 
density). d) The large degree of spacing between clay cross-linkers allow for long and fl exible polymer chains. Adapted with permission. [ 13,14 ] Copyright 
2002, 2006, American Chemical Society. a rigid gel with increased modulus, and strength was obtained 
due to a reorientation of the clay particles. [ 14 , 106 , 121 ] This 
unique combination of injectability, providing the possibility 
of minimally invasive delivery of cells and biomolecules, with 
high mechanical strength and toughness, makes this approach 
of relevance for regeneration of a wide range of hard and soft 
tissues. 
 Despite these marked improvements in elastic modulus, 
the stiffness and toughness achieved are still, in these studies, 
an order of magnitude below that of soft-biological tissues. 
Recently however, Wang et al. [ 149 ] have generated further 
improvements to the mechanics of PNIPA-Laponite nano-
composites by generating gels with an ordered layered struc-
ture mimicking that of nacre. This well ordered micro- and 
nanoscale structure allowed for the incorporation of Laponite 
particles constituting up to 30 wt% and achieved a dramatic, 
360-fold increase in elastic modulus (together with a fi ve-fold 
increase in strength and a six-fold increase in toughness) com-
pared with conventionally produced PNIPA-Laponite nanocom-
posite gels. The 1.5–43 MPa modulus of these ordered gels 80 wileyonlinelibrary.com © 2013 WILEY-VCH Verlagrepresents the highest reported value for a polymeric hydrogel 
to date, and, critically, achieves mechanical properties com-
parable to that of stiff biological tissues such as cartilage and 
cornea, further extending the possible applications of these 
materials for regenerative strategies. [ 149 ] 
 5. Clay–Cell Interactions 
 In response, largely, to the opportunities afforded by clay min-
erals for mechanical enhancement, an emerging cluster of 
studies have investigated the interaction of cells with mate-
rials incorporating clay nanoparticles. The application of clay 
nanoparticles and composites to regenerative medicine is still 
in its infancy however, and (with a few exceptions) little pro-
gress beyond relatively basic in vitro characterization of cellular 
responses to clay substrates has been reported. However, the 
data arising from these studies suggest intriguing potential for 
the control of cell function in the context of niche generation 
and tissue regeneration.  GmbH & Co. KGaA, Weinheim Adv. Mater. 2013, 25, 4069–4086
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 Most studies describe no, or negligible, loss of cell viability 
or proliferation in the presence of clay minerals or materials 
incorporating clay minerals. Early studies on sepiolite-collagen 
complexes observed normal fi broblast proliferation and out-
growth of skin fi broblasts from explants [ 150,151 ] and, while min-
imal bone ingrowth was observed upon implantation into an 
osseous cranial defect, there was no observed toxic or necrotic 
effect on local bone tissue. [ 152 ] Laponite nanoparticles added 
directly to cell culture media did not impact on the viability 
of MC3T3-E1 pre-osteoblasts at doses up to 35 mg mL  − 1 . [ 55 ] 
Normal stromal cell morphology and proliferation was observed 
on Gelatin–MMT–chitosan scaffolds [ 70,71 ] and no inhibition of 
fi broblast proliferation was observed on chitosan g-lactic acid 
MMT composites. [ 74 ] Another study observed no stabilization of 
the foci of histone gamma H2AX, an indication of genotoxic 
action, in fi broblasts cultured on chitosan–MMT composite 
scaffolds. [ 153 ] Polyurethane (PU)–MMT nanocomposites were 
also observed to be capable of sustaining the proliferation of 
cementoblasts. [ 111 ] No acute oral toxicity has been observed 
in rats up to the maximum dose (5700 mg kg  − 1 body weight) 
tested [ 154–156 ] and while MMT could be absorbed into the body 
within 2 h, it was not observed to accumulate in the long term 
in any specifi c organ. [ 155,156 ] 
 A study of the toxicity of exfoliated MMT nanosilicate plate-
lets showed no genotoxicity as assessed by three separate 
assays: the comet assay in Chinese hamster ovary (CHO) cells, 
an in vivo micronucleus assay in peripheral blood cells, and the 
Salmonella gene mutation assay. [ 154 ] Another study confi rmed 
negligible genotoxicity of sodium modifi ed MMT (Cloisite Na  +  ) 
in the Salmonella microsome and comet assays, but did observe 
a genotoxic response using fi ltered suspensions of Cloisite 
30B. This was found to be attributable to the leached quater-
nary ammonium compounds which are frequently employed 
to enhance the dispersion of clay (particularly MMT) with pol-
ymer. [ 157 ] Quaternary ammonium compounds were also found 
to signifi cantly inhibit cell growth when leached from the clay 
under simulated physiological conditions. In this study an 
alternative modifi er, amino undecanoic acid was found to be of 
low toxicity and confer equivalent miscibility. [ 112 ] 
 Despite numerous studies that have observed normal, non-
toxic cell or tissue responses, there remains a degree of ambi-
guity regarding the in vitro cytotoxicity of clay materials. Most 
studies have observed cytotoxicity only at high concentrations. 
For example, a loss of viability in CHO cells as indicated by 
the MTT assay and lactase dehydrogenase (LDH) release was 
observed at high doses of exfoliated MMT nano-silicate plate-
lets (IC 50 of  > 1000  μ g mL  − 1 ). [ 154 ] Similarly, a study into clay 
minerals modifi ed with an amine functional group observed 
minimal cytotoxicity through the MTT and LDH assays in four 
cell types at concentrations of 500  μ g mL  − 1 and only moderate 
cytotoxicity at 1000  μ g mL  − 1 . [ 158 ] Other studies have however 
described a more acute response. A signifi cant loss of cell 
viability was observed in A549 lung epithelial cells following 
24 h treatment with the nanoclays Bentone MA, ME-100, 
Cloisite Na  +  , Nanomer PGV, or Delilite LVF at concentrations 
of 25  μ g mL  − 1 . [ 159 ] Proliferation of INT-407 cells was inhibited 
at MMT concentrations above 100  μ g mL  − 1 after 24–72 h and © 2013 WILEY-VCH Verlag GmAdv. Mater. 2013, 25, 4069–4086clonogenicity was impeded at only 5  μ g mL  − 1 after 10 days. [ 156 ] 
Another study observed a signifi cant loss of viability of HEPG2 
cells at only 1 μ g mL  − 1 concentrations of Cloisite Na  +  after 24 
h. [ 160 ] It should be noted, however, that in these latter studies 
LDH leakage results did not correlate well with the loss of via-
bility, being observed only at high clay concentrations, and thus 
telling against a direct effect of MMT on cell viability. [ 156 , 160 ] 
 More work is needed to elucidate the mechanisms for the 
potential in vitro cytotoxicity of certain clay formulations and 
to account for the lack of consistency between experiments 
assessing the biocompatibility of these materials. One impor-
tant factor that remains to be suffi ciently addressed in these 
studies is the importance of clay interactions with cell-culture 
media components which may mediate the impact of clay on in 
vitro cell viability. For example, a recent study has shown that 
increasing the concentration of the ubiquitous additive FCS 
from 2.5% to 5% attenuates the cytotoxic response of Human 
monocytic U937 cells to Cloisite Na  +  . [ 161 ] 
 Other questions remain about the long-term fate and bio-
compatibility of clay nanoparticles in vivo. These include the 
possibility and impact of their cellular uptake, their potential 
for dissolution within the inter- and intracellular spaces and 
the controversial importance of particle size and surface area in 
effecting the cytotoxicity of nanoparticles. [ 162 ] Despite the long-
term precedent of oral and topical administration of clay parti-
cles, clay minerals are not yet approved by regulatory agencies 
for implantation. Thus, considerable work is still required to 
confi rm the long-term biocompatibility of the various clay min-
erals before clinical application for TERM strategies. 
 5.2. Cell Adhesion and Proliferation 
 Notwithstanding lingering questions regarding cytocompat-
ibility, an increasing number of studies have shown not only 
normal cellular responses, but clay-dependent enhancements, 
particularly in respect to cell adhesion and proliferation upon 
polymeric matrices and gel substrates. Haraguchi et al. [ 84 ] 
investigated the effect of clay content in Laponite nanoparticle 
cross-linked PNIPA hydrogels on cell viability, adhesion, and 
proliferation. Consistent with previous studies [ 163,164 ] organi-
cally cross-linked PNIPA polymeric hydrogels alone were 
unable to support the adhesion of proliferating cells. Clay cross-
linked PNIPA however, was able to maintain both the adhesion 
and proliferation of HepG2, skin fi broblast, and human umbil-
ical vein endothelial cells (HUVECs) in a manner strongly 
associated with the concentration of clay in the hydrogel. Inter-
estingly above a critical concentration of clay (7  × 10  − 2 mol L  − 1 ) 
cell adhesion was again impeded. The reason for the strong 
dependency of cellular adhesion on clay content in this system 
remains unclear but the authors propose attenuation of the 
hydrophobicity of the contracted PNIPA substrate by the hydro-
philic clay particles, the surface anionic charges conferred by 
the clay and improved protein adsorption as possible explana-
tions. Importantly, the previously established utility of PNIPA 
polymers grafted to tissue culture plastic (TCP) for tempera-
ture dependent cell sheet detachment [ 164 ] is preserved in the 
clay–PNIPA nanocomposite hydrogels, allowing the use of this 
approach for cell-sheet engineering applications. [ 84 , 165 ] 4081wileyonlinelibrary.combH & Co. KGaA, Weinheim
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 Figure  9 .  Improved adhesion and proliferation of MSCs on PEO gel fi lms with increasing incorporation of Laponite nanoparticles. Adapted with per-
mission. [ 15 ] Copyright 2012, Wiley-VCH.  The same group also observed a bimodal response to clay 
content on MSC proliferation on 2-methoxyethyl acrylate 
(MEA) and N,N-dimethylacrylamide (DMAA) co-polymer clay 
nanocomposite gel fi lms. In this case, while cell adhesion was 
dependent on the presence of clay nanoparticles and increasing 
the clay concentration from 0.02 molar to 0.05 molar further 
enhanced cell adhesion (recorded at day 3), the increase in clay 
concentration also coincided with a slowing of proliferation 
over the seven day culture period. [ 86 ] 
 Similar clay dependent effects on cell adhesion and prolifera-
tion have been seen in several other studies. Addition of 2.5 wt% 
Laponite was found to be suffi cient to sustain the adhesion 
and proliferation of hMSCs on otherwise poorly cell adhesive 
PEG hydrogel fi lms. The authors suggested a possible role for 
Laponite nanoparticles, both in providing adhesive sites for cell 
attachment and in facilitating protein adsorption. [ 85 ] Enhanced 
adhesion of primary dermal fi broblasts onto chitosan fi lms was 
improved with addition of 5% MMT [ 153 ] and enhanced prolif-
eration of osteoblasts was also seen with MMT incorporation 
into chitosan-PGA fi lms. [ 73 ] In another study, the incorpora-
tion of 6 wt% MMT into a porous gelatin–cellulose composite 
reversed the observed negative impact of the cellulose compo-
nent on cell viability and adhesion, and instead dramatically 
enhanced the proliferation of SAOS2 cells over and above the 
TCP control. The effect was further accentuated when the MMT 2 wileyonlinelibrary.com © 2013 WILEY-VCH Verlag Gcontent was increased to 12 wt%. [ 166 ] Addition of 5% Cloisite 
20A clay signifi cantly enhanced cell spreading and proliferation 
over ethylene vinyl acetate (EVA) fi lms and addition of 10% clay 
further enhanced proliferation, which exceeded that observed 
on the glass surface control. Further increase in clay concen-
tration however, impeded proliferation. The authors discuss the 
possible role surface modulus plays in this dynamic, though 
other possible factors including the concentration of leached 
organic modifi er were not addressed. [ 112 , 167 ] 
 Recent work by Gaharwar and colleagues on Laponite-PEO 
nanocomposite fi lms [ 15 , 55 , 77 , 83 , 106 ] has started to shed some light 
on the function of clay in facilitating adhesion and prolifera-
tion of cells on polymeric gels. As with many of the polymers 
described above, PEO is hydrophilic and non-fouling and, thus, 
is resistant to cellular adhesion. The adhesion of NIH3T3 fi bro-
blasts, [ 83 , 106 ] MC3T3-E1 preosteoblasts, [ 55 ] and mesenchymal 
stem cells [ 15 ] was found to be highly dependent on the ratio of 
Laponite added to PEO such that only at ratios of Laponite to 
PEO of 40% and above were fi broblasts observed to adhere and 
proliferate ( Figure  9 ). Increasing the clay content up to 70% 
further enhanced cell proliferation. Importantly, this effect was 
consistently observed not only in the growth phase, but also in 
the total number of cells reached at the (sub-confl uent) plateau 
phase, indicating the availability of adhesion sites provided by 
the clay to be a controlling factor. [ 83 , 106 ] Furthermore, fi broblast mbH & Co. KGaA, Weinheim Adv. Mater. 2013, 25, 4069–4086
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ence of serum proteins in the media, as suggested by several 
of the above studies. Interestingly, in contrast to tissue culture 
polystyrene and PEO diacrylate controls, some cell adhesion fol-
lowing a clay concentration trend was still observed in serum-
free conditions. Thus, in addition to providing protein adhesion 
sites, these studies suggest direct cell–clay interactions can also 
mediate cell adhesion, albeit less effi ciently, in the absence of 
adhesive factors adsorbed from the serum. [ 83 ] 
 5.3. Cell Differentiation 
 The possibility of harnessing clay minerals for the induction 
of cellular differentiation is implied by the well-established 
utility of clay minerals for the localization of biomolecules. To 
date however, this possibility has been scarcely explored for 
regenerative strategies. In preliminary studies, we have demon-
strated the potential to enhance the chondrogenic differentia-
tion of MSCs in electrolyte induced clay colloid gel capsules by 
co-localizing the matrix molecule fi bronectin with the encapsu-
lated populations. [ 12 ] 
 Aside from the largely unexplored potential of clay nano-
particles to mediate the differentiation of regenerative popula-
tions via the localization of biological signals, several studies 
have suggested the utility of clays to stimulate the osteogenic 
induction of responsive cells via direct clay–interactions. For 
example, the response of a pre-osteoblast cell line to osteogenic 
induction has been investigated as a function of Laponite con-
tent in PEO nanocomposite fi lm surfaces. [ 55 ] Similar to the 
observed Laponite-dependent enhancement of adhesion and 
proliferation of preosteoblasts described above, an increase 
in Laponite concentration from 40% to 70% resulted in a 
10-fold increase in alkaline phosphatase activity and a 12-fold 
increase in mineralized matrix production after 28 days in vitro 
culture. The authors discuss the potential effect of Laponite 
nanoparticles in directly upregulating osteogenesis via the elu-
tion of Mg2 + and silicate ions, a function well-established in 
bioglass, another silicate based material, and certain bioactive 
ceramics. [ 55 ] It should be noted however, that in this case, the 
enhanced response to induction could be accounted for simply 
as a function of improved cell adhesion and spreading con-
ferred by Laponite, particularly since the alkaline phosphatase 
expression did not exceed that observed in the TCP control. 
Another study by the same group investigating osteogenic 
induction of human MSCs (passage 5) on PEO-Laponite nano-
composites, did however observe enhanced upregulation of 
osteocalcin mRNA compared to controls raising the possibility 
of direct clay induced enhancement of osteogenesis. [ 15 ] 
 Further evidence suggesting a role for clay nanoparticles as 
a source of osteoinductive silica species was also presented in a 
study in which silk fi broin fi lms were doped with Cloisite Na  +  . 
Compared with TCP and sodium silicate modifi ed silk fi lms, 
human MSCs (passage 2/3) cultured on MMT treated fi lms for 
14 days in osteogenic culture conditions showed signifi cantly 
increased expression of alkaline phosphatase, bone sialopro-
tein, and type I collagen compared to controls. The authors 
inferred that the presence of low levels of silica ions detected by 
inductively coupled plasma analysis in MMT treated samples © 2013 WILEY-VCH Verlag GAdv. Mater. 2013, 25, 4069–4086may account for the enhanced osteogenic response. [ 168 ] Another 
study observed enhanced MSC osteogenesis on electrospun 
PCL nanocomposite fi bers that incorporated halloysite as 
matrices for bone tissue engineering. Interestingly, this study 
observed that the addition of 4% halloysite improved both pro-
tein adsorption and the deposition of hydroxyapatite (HA) from 
simulated body fl uid compared with PCL fi bers alone. [ 87 ] The 
ability of the inter-gallery regions of organically modifi ed MMT 
to act as sites for the mineralization of HA was also observed 
in a further study. The generated HA-organoclay nanoparticles 
were subsequently incorporated into Chitosan PGA fi lms to 
support the adhesion and growth of human osteoblasts. [ 169 ] 
These pioneering studies into the utility of clay minerals to 
induce the osteogenic differentiation of osteoprogenitors thus 
suggest a range of possible mechanisms. As well as acting as a 
potential source of osteoinductive ions the ability of clay min-
erals to enhance cellular adhesion, adsorb protein and facilitate 
mineralization may also play a role in the observed enhance-
ment of osteogenesis. Further studies are thus warranted to 
elucidate and confi rm this novel application for clay minerals. 
 6. Conclusions and Future Directions 
 This Progress Report has described the interactions of clay 
nanoparticles with biological molecules, polymers, and cells. 
Each of these interactions present new opportunities for 
TERM that are only beginning to be explored (Figure  1 ). We 
have described the application of clay–biomolecule interac-
tions in drug and gene delivery systems, including drug-
release from polymeric matrices and scaffolds. As well as 
controlled release, the utility of clay nanoparticle systems to 
localize biological signaling has recently been explored in the 
development of spatially complex regenerative microenviron-
ments. [ 12 , 80 ] While the rich array of potential binding mecha-
nisms/sites clay minerals offer provides considerable potential 
for this, it also presents challenges in predicting the precise 
nature of protein–clay interactions and the resulting bioavail-
ability and effi cacy of the localized molecule. Such complexity 
suggests the need for high-throughput empirical approaches 
able to confi rm the biological function of molecules in asso-
ciation with clay nanoparticles. A further avenue still to be 
explored in the context of TERM is the utility of clay nano-
particles for gene delivery in situ. The ability to both sustain 
and localize the infl uence of a delivered vector is an ongoing 
challenge and the established ability of clay minerals to bind 
nucleotides, and offer a degree of protection from enzymatic 
digestion could contribute in the pursuit of a safe and reliable 
in situ transfection technology. 
 Of the interactions reviewed, clay–polymer interactions 
remain the most extensively investigated. This Progress Report 
has described the unique ability of clay–polymer nanocom-
posites to marry important biomaterial parameters such as 
porosity or self-organization with mechanical strength and 
toughness. The ability to generate strong porous scaffolds with 
strength and stiffness equivalent to trabecular bone, and poly-
meric hydrogels combining the potential for minimally inva-
sive delivery with the toughness characteristic of soft biological 
tissues, extends the potential utility of these materials across 4083wileyonlinelibrary.commbH & Co. KGaA, Weinheim
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applications. 
 The success of this approach and the potential it offers for 
biomaterial design has, to date, been the main drive behind 
investigations into clay–cell interactions (Figure  1 ). The 
enhancements in cell adhesion, proliferation, and differentia-
tion in response to clay nanoparticles observed in these studies 
suggest intriguing potential for control of cellular responses to 
biomaterial surfaces and warrant further work elucidating the 
mechanisms involved. 
 The application of these material strategies presents consid-
erable potential for the generation of multifunctional scaffolds 
for TERM strategies. While, as noted in the introduction, the 
inductive role of the TERM scaffold is increasingly empha-
sized within the fi eld, the marrying of such regenerative func-
tions with the still vital “conductive” clinical design constraints 
such as mechanical support and minimally invasive delivery 
remains a considerable challenge in scaffold design. [ 11 ] If the 
interactions described in this Progress Report can be success-
fully harnessed in combination to allow concurrent localization 
of biological molecules, enhancement of polymer mechanics, 
and induction of cellular responses, this signifi cant challenge 
to the clinical translation of regenerative strategies may begin 
to be met. 
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